- $2.57m
- $21.00m
- $66.86m
- 29
- 73
- 19
- 34
Annual income statement for Cemtrex, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 43.5 | 43.1 | 45 | 59.4 | 66.9 |
| Cost of Revenue | |||||
| Gross Profit | 17.6 | 17 | 16.6 | 25.7 | 27.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 48.1 | 51.9 | 59.2 | 60.9 | 72.1 |
| Operating Profit | -4.57 | -8.74 | -14.1 | -1.51 | -5.27 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.36 | 0.769 | -10.8 | -6 | -7.48 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.43 | 0.394 | -10.6 | -6.4 | -7.68 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -10.5 | -7.81 | -13 | -9.2 | -7.23 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.5 | -7.81 | -13.2 | -9.52 | -7.23 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1,231 | 30.6 | -413 | -269 | -17 |